PixCell Medical Acquired by Soulbrain Holdings
South Korea-based Soulbrain Holdings has acquired all controlling PixCell shares, making Soulbrain the majority shareholder of PixCell Medical.
Read More
Search Results for: point-of-care
Sense Raises $50M to Accelerate Launch of Covid-19 Molecular Test
Sense Biodetection has raised a $50 million Series B investment to advance commercialization of its Veros covid-19 product and continue development of a portfolio of instrument-free, rapid molecular tests.
Read More
RADx Expands Covid-19 Home and POC Testing, Wastewater Surveillance
NIH announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel covid-19 testing technologies.
Read More
Qorvo Awarded $24.4M NIH Contract to Scale POC Covid-19 Antigen Testing
The NIH contract through RADx helps advance the production and market launch of the Qorvo Omnia diagnostic test platform.
Read More
Qorvo Gets FDA EUA for Omnia Rapid Covid-19 Antigen Testing
The Qorvo Omnia SARS-CoV-2 Antigen Test is authorized for the qualitative detection of nucleocapsid viral antigens from SARS-CoV-2 in nasal swab specimens from individuals who are suspected of covid-19.
Read More